{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:24:43Z","timestamp":1776122683921,"version":"3.50.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.juro.2009.11.044","type":"journal-article","created":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T09:29:40Z","timestamp":1264066180000},"page":"940-945","source":"Crossref","is-referenced-by-count":27,"title":["Prostate Specific Antigen Decrease and Prostate Cancer Diagnosis: Antibiotic Versus Placebo Prospective Randomized Clinical Trial"],"prefix":"10.1097","volume":"183","author":[{"given":"R.M.","family":"Stopiglia","sequence":"first","affiliation":[{"name":"Section of Urologic Oncology, Discipline of Urology, State University of Campinas \u2013 UNICAMP, Campinas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Section of Urologic Oncology, Discipline of Urology, State University of Campinas \u2013 UNICAMP, Campinas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Silva","sequence":"additional","affiliation":[{"name":"Section of Urologic Oncology, Discipline of Urology, State University of Campinas \u2013 UNICAMP, Campinas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.E.","family":"Matheus","sequence":"additional","affiliation":[{"name":"Section of Urologic Oncology, Discipline of Urology, State University of Campinas \u2013 UNICAMP, Campinas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Denardi","sequence":"additional","affiliation":[{"name":"Section of Urologic Oncology, Discipline of Urology, State University of Campinas \u2013 UNICAMP, Campinas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.O.","family":"Reis","sequence":"additional","affiliation":[{"name":"Section of Urologic Oncology, Discipline of Urology, State University of Campinas \u2013 UNICAMP, Campinas, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2009.11.044_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2009.11.044_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0090-4295(99)00205-8","article-title":"Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network","volume":"54","author":"Nickel","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.11.044_bib3","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0022-5347(05)67026-7","article-title":"Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen","volume":"164","author":"Potts","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib4","first-page":"365","article-title":"Asymptomatic prostatitis: a frequent cause of raising PSA","volume":"96","author":"Terrone","year":"2005","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.juro.2009.11.044_bib5","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.juro.2008.01.034","article-title":"Evaluation of prostatitis in autopsied prostates\u2013is chronic inflammation more associated with benign hyperplasia or cancer?","volume":"179","author":"Delongchamps","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urolonc.2008.04.002","article-title":"Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)","volume":"27","author":"Loeb","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2009.11.044_bib7","first-page":"492","article-title":"Bacteriologic localization patterns in bacterial prostatitis and urethritis","volume":"5","author":"Mears","year":"1968","journal-title":"Invest Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncpuro0702","article-title":"The responsible use of antibiotics for an elevated PSA level","volume":"4","author":"Scardino","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.pcan.4500885","article-title":"Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng\/ml","volume":"9","author":"Kaygisiz","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2009.11.044_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0094-0143(05)70374-8","article-title":"The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration","volume":"24","author":"Tchetgen","year":"1997","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.juro.2009.11.044_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.med.57.011205.135654","article-title":"Prostatitis\/chronic pelvic pain syndrome","volume":"57","author":"Habermacher","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.juro.2009.11.044_bib12","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.juro.2006.06.103","article-title":"Modeling prostate specific antigen kinetics in patients on active surveillance","volume":"176","author":"Zhang","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0090-4295(99)80450-6","article-title":"Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population","volume":"47","author":"Komatsu","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.11.044_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-5347(01)67064-2","article-title":"Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels","volume":"154","author":"Nadler","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.eururo.2004.08.003","article-title":"Effect of NIH-IV prostatitis on free and free-to-total PSA","volume":"46","author":"Stancik","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.11150\/kansenshogakuzasshi1970.77.611","article-title":"Prostate histopathology of NIH category IV prostatitis detected by sextant prostate needle biopsy from the patients with high prostatic specific antigen","volume":"77","author":"Shimomura","year":"2003","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.juro.2009.11.044_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11255-004-0845-x","article-title":"Does asymptomatic inflammation increase PSA?","volume":"36","author":"G\u00fcm\u00fc\u015f","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.juro.2009.11.044_bib18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.urology.2004.08.060","article-title":"Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study","volume":"64","author":"Simardi","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.11.044_bib19","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0022-5347(05)65186-5","article-title":"Treatment of chronic prostatitis lowers serum prostate specific antigen","volume":"167","author":"Bozeman","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib20","first-page":"154","article-title":"PSA decrease after levofloxacin therapy in patients with histological prostatitis","volume":"76","author":"Guercio","year":"2004","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.juro.2009.11.044_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.pcan.4500996","article-title":"PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients","volume":"11","author":"Serretta","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2009.11.044_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1159\/000052500","article-title":"Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng\/ml and nonsuspicious results of digital rectal examination","volume":"39","author":"Karazanashvili","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000089730","article-title":"Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies?","volume":"76","author":"Erol","year":"2006","journal-title":"Urol Int"},{"key":"10.1016\/j.juro.2009.11.044_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000112612","article-title":"Serum PSA and percent free PSA value changes after antibiotic treatment","volume":"80","author":"Kobayashi","year":"2008","journal-title":"Urol Int"},{"key":"10.1016\/j.juro.2009.11.044_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.juro.2008.09.020","article-title":"Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen","volume":"181","author":"Baltac\u0131","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.11.044_bib26","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < 4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709029358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709029358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2009.11.044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:52:01Z","timestamp":1651197121000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2009.11.044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1016\/j.juro.2009.11.044"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2009.11.044","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}